AVITA Medical reports PermeaDerm study results with 70% economic advantage
AVITA Medical says its PermeaDerm study demonstrates a 70% economic advantage versus allograft and reports comparable clinical outcomes.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.